Pathological and positron emission tomographic correlations in Alzheimer's disease.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 2857310)

Published in Lancet on January 26, 1985

Authors

R P Friedland, A Brun, T F Budinger

Articles citing this

Cognitive reserve. Neuropsychologia (2009) 8.41

Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol (2012) 4.25

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32

Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08

Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49

Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry (1987) 1.39

Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta (2011) 1.34

Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study. J Neurol Neurosurg Psychiatry (2001) 1.14

Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging (2008) 0.96

Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry (1987) 0.90

APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging (2012) 0.88

Taste in mild cognitive impairment and Alzheimer's disease. J Neurol (2009) 0.86

Cognitive reserve: implications for assessment and intervention. Folia Phoniatr Logop (2013) 0.84

Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals. Front Syst Neurosci (2014) 0.82

Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment. Int Rev Neurobiol (2009) 0.80

Dominantly inherited Alzheimer's disease: cerebral glucose metabolism. J Neurol Neurosurg Psychiatry (1987) 0.80

Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Arch Neurol (2010) 0.79

EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug. Br J Clin Pharmacol (1989) 0.79

Comparability of [(18)F]THK5317 and [(11)C]PIB blood flow proxy images with [(18)F]FDG positron emission tomography in Alzheimer's disease. J Cereb Blood Flow Metab (2016) 0.77

Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging (2005) 0.77

Imaging of Common Adult Neurologic Disorders: Imaging methods used to evaluate patients with neurologic disease. Can Fam Physician (1991) 0.75

Articles by these authors

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92

The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis. Nature (2008) 5.42

Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology (1981) 3.08

Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med (1983) 3.08

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol (1986) 3.04

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol (2000) 2.98

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer (1981) 2.06

Electromagnetic fields of surface coil in vivo NMR at high frequencies. Magn Reson Med (1991) 1.88

Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med (1988) 1.87

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr (1983) 1.77

Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr (1970) (1976) 1.77

Epidemiology, education, and the ecology of Alzheimer's disease. Neurology (1993) 1.73

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol (1990) 1.62

Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med (2001) 1.58

Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol (2007) 1.57

Smoking and cognitive impairment: a population-based study. J Am Geriatr Soc (1996) 1.56

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol (1996) 1.54

White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain (1988) 1.53

Physiology of organic nitrogen acquisition by ectomycorrhizal fungi and ectomycorrhizas. FEMS Microbiol Rev (1998) 1.52

Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med (1992) 1.50

Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Brain Pathol (1996) 1.47

Isolation and characterization of a new peroxiredoxin from poplar sieve tubes that uses either glutaredoxin or thioredoxin as a proton donor. Plant Physiol (2001) 1.46

NMR of laser-polarized xenon in human blood. Proc Natl Acad Sci U S A (1996) 1.46

Abnormal connectivity of the visual pathways in human albinos demonstrated by susceptibility-sensitized MRI. Neurology (1994) 1.44

Emission computer assisted tomography with single-photon and positron annihilation photon emitters. J Comput Assist Tomogr (1977) 1.44

Mannosidosis: a clinical and histopathologic study. J Pediatr (1969) 1.44

A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39

The subpial granular layer of the foetal cerebral cortex in man. Its ontogeny and significance in congenital cortical malformations. Acta Pathol Microbiol Scand (1965) 1.37

Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol (1982) 1.36

Nuclear magnetic resonance (NMR) in vivo studies: known thresholds for health effects. J Comput Assist Tomogr (1981) 1.35

The Swedish Centenarian Study: a multidisciplinary study of five consecutive cohorts at the age of 100. Int J Aging Hum Dev (1997) 1.35

Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol (2003) 1.34

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol (2000) 1.31

Cerebrospinal fluid production is reduced in healthy aging. Neurology (1990) 1.31

Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27

Limbic lobe involvement in presenile dementia. Arch Psychiatr Nervenkr (1970) (1978) 1.24

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology (1996) 1.24

Prevalence of Alzheimer's type dementia in an elderly Arab population. Eur J Neurol (2001) 1.23

The diagnosis of dementia with single photon emission computed tomography. Arch Neurol (1987) 1.21

Heterogeneity of diffusion inside microbial biofilms determined by fluorescence correlation spectroscopy under two-photon excitation. Photochem Photobiol (2002) 1.21

Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol (1988) 1.20

Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology (1988) 1.18

White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology (1990) 1.17

High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology (1993) 1.17

Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes. Arch Gerontol Geriatr (1987) 1.15

Sex and electroencephalographic synchronization after photic stimulation predict signal changes in the visual cortex on functional MR images. AJNR Am J Neuroradiol (1998) 1.14

Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology (2009) 1.12

Characterization of p30, a highly antigenic membrane and secreted protein of African swine fever virus. Virology (1992) 1.12

The Drosophila cytochrome P450 gene Cyp6a2: structure, localization, heterologous expression, and induction by phenobarbital. DNA Cell Biol (1997) 1.11

Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest (1982) 1.11

Disposal of blood [1-13C]lactate in humans during rest and exercise. J Appl Physiol (1985) (1986) 1.11

The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology (1998) 1.11

Survival after severe cerebral anoxia with destruction of the cerebral cortex: the apallic syndrome. Ann N Y Acad Sci (1978) 1.10

A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun (1993) 1.09

Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry (1996) 1.08

Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry (1985) 1.07

Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry (1985) 1.07

Worker functions and traits associated with occupations and the development of AD. Neurology (2004) 1.07

Measurement of 129Xe T1 in blood to explore the feasibility of hyperpolarized 129Xe MRI. J Comput Assist Tomogr (1996) 1.06

Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab (1991) 1.06

Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation. J Neurosci (2004) 1.06

Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry (1988) 1.06

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer (1991) 1.05

Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia (1996) 1.05

Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett (1985) 1.05

Instrumentation trends in nuclear medicine. Semin Nucl Med (1977) 1.04

Multipole shimming of permanent magnets using harmonic corrector rings. Rev Sci Instrum (2007) 1.03

Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03

Influence of metabolic fuel on the 13C/12C ratio of breath CO2. Biomed Mass Spectrom (1984) 1.02

Marginal glioneural heterotopias of the central nervous system. Acta Pathol Microbiol Scand (1965) 1.02

Structural nerve changes at wrist level in workers exposed to vibration. Occup Environ Med (1997) 1.02

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology (1988) 1.01

Retrieval from semantic memory in Alzheimer-type dementia. J Clin Exp Neuropsychol (1986) 1.01

Permeability of the blood-brain barrier induced by 915 MHz electromagnetic radiation, continuous wave and modulated at 8, 16, 50, and 200 Hz. Microsc Res Tech (1994) 1.01

A microfluorometric method for measuring ethoxycoumarin-O-deethylase activity on individual Drosophila melanogaster abdomens: interest for screening resistance in insect populations. Anal Biochem (1995) 1.01

Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm. J Comput Assist Tomogr (1996) 1.01

The use of filtering methods to compensate for constant attenuation in single-photon emission computed tomography. IEEE Trans Biomed Eng (1981) 1.00

The RG2 rat glioma model. J Neurooncol (1995) 0.98

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg (1988) 0.98

Magnetohydrodynamics of blood flow. Magn Reson Med (1990) 0.98

Hemi-inattention and hemisphere specialization: introduction and historical review. Adv Neurol (1977) 0.98

Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem (1970) 0.98

The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J Neural Transm Park Dis Dement Sect (1989) 0.98

CNS malformations in Turner's syndrome. An integral part of the syndrome? Acta Neuropathol (1968) 0.98

Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology (2002) 0.98

Spectrum of frontal lobe dementia in a Swedish family. Dementia (1993) 0.97

Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord (1997) 0.97

The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. Neurology (2000) 0.97

Ten precepts for quantitative data acquisition and analysis. Circulation (1985) 0.97

Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. J Clin Exp Neuropsychol (1991) 0.97

EEG in presenile dementia related to cerebral blood flow and autopsy findings. Acta Neurol Scand (1977) 0.96

An African swine fever virus gene with similarity to the T-lymphocyte surface antigen CD2 mediates hemadsorption. Virology (1994) 0.96

Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection. FEBS Lett (2005) 0.96

Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features. J Psychiatr Res (1990) 0.96

Region-selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. J Neurochem (2002) 0.96